DSI
REGN icon

Daiwa SB Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Daiwa SB Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-580
Closed -$270K – 165
2015
Q3 		$270K Hold
580
– – 0.06% 129
2015
Q2 		$296K Hold
580
– – 0.06% 143
2015
Q1 		$262K Sell
580
-60
-9% -$25.4K 0.05% 135
2014
Q4 		$263K Buy
+640
New +$252K 0.04% 126

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Daiwa SB Investments's REGN Position: Q4 2015 in Review

Daiwa SB Investments sold out of Regeneron Pharmaceuticals (REGN) in Q4 2015, closing a stake of 580 shares — an estimated $270K sold.

Daiwa SB Investments first reported a position in REGN in Q4 2014 and held it in 4 quarters. The position peaked at $296K in Q2 2015. 577 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

  • Daiwa SB Investments reported no remaining Regeneron Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Daiwa SB Investments sold 580 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $270K.
  • Daiwa SB Investments first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Daiwa SB Investments's Regeneron Pharmaceuticals position peaked at $296K in Q2 2015.
  • 577 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on Daiwa SB Investments's 13F filing for Q4 2015, filed 8 Jan 2016.